US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 24.230
  • +0.960+4.13%
Trading May 3 10:12 ET
2.34BMarket Cap-4470P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept ARK Holdings
ARK Holdings
Intraday+1.23%
Gene Editing
Gene Editing
Intraday+0.75%